Ovarian function | Normal | Abnormal | |
---|---|---|---|
n (%) | n (%) | ||
Patients | 7 (21) | 27 (79) | |
Age at HCT, yr | 5.3 ± 1.2 | 7.4 ± 0.7 | |
Age at evaluation, yr | 14.7 ± 0.6 | 13.7 ± 0.3 | |
Interval between HCT and evaluation, yr | 9.4 ± 0.8 | 6.3 ± 0.7 | |
Conditioning | |||
TBI | 3 (13) | 21 (87) | |
TLI | 1 (33) | 2 (67) | |
Chemotheray alone | 3 (43) | 4 (57) | |
Cyclophosphamide | + | 4 (18) | 18 (82) |
- | 3 (25) | 9 (75) | |
Busulfan | + | 1 (12) | 7 (88) |
- | 6 (23) | 20 (77) | |
Melphalan | + | 3 (30) | 7 (70) |
- | 4 (17) | 20 (83) | |
Inhibin B, pg/mL | 87 ± 20 | 18.6 ± 4.3* | |
n = 7 | |||
Partial ovarian failure, n = 11 | |||
26.9 ± 10ª | |||
Complete ovarian failure, n = 16 | |||
12.9 ± 1.1 | |||
AMH, pmol/L | 0.7 ± 0.4 | 0.1 ± 0.1ª | |
n = 7 | n = 18 |